| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Shefferman Jesse | CEO and President, Director | C/O PROTARA THERAPEUTICS, INC., 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK | /s/ Jesse Shefferman | 22 Jan 2026 | 0001799167 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TARA | Common Stock | Tax liability | $91,403 | -16,322 | -1.6% | $5.60 | 1,030,564 | 20 Jan 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024. |